Constrained Fetal Hematopoiesis and Clonal Restriction in Fanconi Anemia
Constrained Fetal Hematopoiesis and Clonal Restriction in Fanconi Anemia
批准号:
10591494
负责人:
Peter Kurre
金额:
$64.01万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-04-01 至 2025-03-31
关键词:
AccelerationActivity CyclesAdultAffectAgeAldehydesAllelesAutomobile DrivingBase PairingBirthBone MarrowBone marrow failureCell CompartmentationCell CountCell CycleCell Cycle CheckpointCell Cycle KineticsCellsCellular StressClonalityCodeComplementDNA Interstrand Cross-Link RepairDNA RepairDNA Repair DisorderDataDefectDevelopmentEnvironmentFANCD2 proteinFailureFanconi anemia proteinFanconi&aposs AnemiaFetal LiverFrequenciesGene ExpressionGenesGenetic RecombinationGenome StabilityGenomic InstabilityHematopoiesisHematopoieticHematopoietic stem cellsHemorrhageHereditary DiseaseHeritabilityImmunophenotypingInflammationInheritedKnockout MiceLeadLifeMeasuresModelingMorbidity - disease rateMusMutationNuclear TranslocationNucleotidesPathogenesisPathway interactionsPatientsPatternPhenotypePhysiologicalPlayPopulationPositioning AttributeProductionReportingReserve Stem CellResolutionRiskRisk FactorsRoleS phaseSchool-Age PopulationShapesSignal PathwaySignal TransductionTP53 geneTestingThrombopoietinTransforming Growth Factor betabiological adaptation to stressbone losscancer predispositioncell typecytopeniaexhaustionexperiencefetalfetal bloodgenome integritygenome-widehematopoietic stem cell expansionhematopoietic stem cell nichehematopoietic stem cell self-renewalhematopoietic transplantationimprovedin uteroinhibitorinsightleukemialoss of functionmortalitymouse modelnovelnovel therapeuticspharmacologicpostnatalpressureprogramsreplication stressresponserestorationself-renewalsingle cell analysisstem cellswhole genome
中文摘要
摘要
该方案基于我们的发现探索了范可尼贫血(FA)发病的新模式。
蛋白质保护造血干细胞在快速发育过程中免受复制应激的影响
胎儿肝脏扩张(FL)。FA是一种隐性遗传性DNA修复障碍,具有癌症易感性
近乎均匀的骨髓(BM)衰竭。而大多数FA患者在早期就经历了症状性衰竭
在学龄期,骨髓造血干细胞(HSC)的数量在生命的早期就已经受损。我们
最近报道,FA基因敲除小鼠的HSC生理缺陷发生在子宫内。我们现在
结果表明,FA缺陷首先出现在FL,由复制应激相关的ATR/Chk1检查点引起
参与免疫表型定义的HSC。因为HSC池通常在出生时就已经完成,
这些限制不仅构成了在FA形成HSC池之前未被认识到的瓶颈,而且
也是导致出生后HSC迅速耗尽的主要危险因素。理解被夸大的事物
足总外语中的发育脆弱性我们已经对外语进行了额外的初步研究
一种微环境,涉及形成HSC生态位的支持细胞的子集。总而言之,我们
假设FA蛋白的生理作用是保护HSC池克隆和基因组
在复制胁迫条件下的完整性。这些观察结果让我们测试了以下因素的长期影响
胎儿FA对HSC自我更新和造血储备的影响。
具体目标1可确定绝对HSC池大小和克隆多样性是以下疾病的驱动风险因素
FA中的HSC耗尽
具体目标2:剖析检查点激活对基因组稳定性和
胎儿FA-HSC的功能
特定目标3:识别导致造血缺陷的FL特定小生境异常
并揭示了在功能上限制HSC扩展的关键信号通路
总而言之,该项目提出了一种新的范式,使FA蛋白能够实现发育扩张
以及自我更新分裂对克隆多样性和HSC池中基因组的稳定性至关重要。这个职位
FA患者的发育缺陷是HSC衰竭的驱动危险因素和关键原因
发病率和死亡率。研究结果将为安全有效的新疗法的开发提供洞察力
减轻FA患者的造血功能丧失。
英文摘要
Summary
This proposal explores a new model of Fanconi Anemia (FA) pathogenesis based on our findings that FA
proteins protect hematopoietic stem cells (HSCs) from replication stress during the rapid developmental
expansion in the fetal liver (FL). FA is a recessively inherited DNA repair disorder with cancer predisposition
and near uniform bone marrow (BM) failure. While most FA patients experience symptomatic failure in early
school age, BM hematopoietic stem cell (HSC) numbers are already compromised much earlier in life. We
recently reported that the physiologic onset of HSC deficits in FA knockout mice occurs in utero. We now
show that deficits in FA first emerge in the FL, caused by replication stress-associated Atr/Chk1 checkpoint
engagement in immunophenotypically defined HSC. Because the HSC pool is typically complete at birth,
these constraints constitute not only a previously unrecognized bottleneck for HSC pool formation in FA, but
also pose a principal risk factor for rapid postnatal HSC exhaustion. To understand the exaggerated
developmental vulnerability in the FA FL we have conducted additional preliminary studies of the FL
microenvironment that implicate a subset of supportive cells forming the HSC niche. Altogether, we
hypothesize that the physiological role of FA proteins is to safeguard in HSC pool clonality and genome
integrity under conditions of replication stress. These observations lead us to test the long-term impact of
fetal deficits in FA on HSC self-renewal and hematopoietic reserve.
Specific Aim 1 ïDetermine absolute HSC pool size and clonal diversity as driving risk factors for
HSC exhaustion in FA
Specific Aim 2 ïDissect the long-term impact of checkpoint activation on genome stability and
function in fetal FA HSC
Specific Aim 3 ïIdentify the FL specific niche abnormalities that contribute to hematopoietic deficits
in FA, and reveal the key signaling pathways that functionally limit HSC expansion
Altogether, this project advances a new paradigm, whereby FA proteins enable developmental expansion
and self-renewal divisions critical to clonal diversity and genome stability in the HSC pool. This positions
developmental deficits in FA patients as a driving risk factor for HSC exhaustion and a critical cause for
morbidity and mortality. Results will provide insight for the development of safe and effective new therapies
that mitigate loss of hematopoietic function in FA.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Hematopoietic stem and progenitor cell regulation of the niche through extracellular vesicles
-
批准号:10634681
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2022
-
负责人:Peter Kurre
-
依托单位:
Constrained Fetal Hematopoiesis and Clonal Restriction in Fanconi Anemia
-
批准号:10377337
-
项目类别:
-
资助金额:$56.44万
-
财政年份:2020
-
负责人:Peter Kurre
-
依托单位:
Mitotically Stable Lentiviral Episomes for Stem Cell Gene Therapy
-
批准号:9348639
-
项目类别:
-
资助金额:$13.79万
-
财政年份:2015
-
负责人:Peter Kurre
-
依托单位:
Mitotically Stable Lentiviral Episomes for Stem Cell Gene Therapy
-
批准号:9020642
-
项目类别:
-
资助金额:$24.26万
-
财政年份:2015
-
负责人:Peter Kurre
-
依托单位:
HSC transduction in situ by cellular delivery of integrating viral vectors
-
批准号:8532025
-
项目类别:
-
资助金额:$36.65万
-
财政年份:2008
-
负责人:Peter Kurre
-
依托单位:
HSC transduction in situ by cellular delivery of integrating viral vectors
-
批准号:7670405
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2008
-
负责人:Peter Kurre
-
依托单位:
HSC transduction in situ by cellular delivery of integrating viral vectors
-
批准号:7902251
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2008
-
负责人:Peter Kurre
-
依托单位:
HSC transduction in situ by cellular delivery of integrating viral vectors
-
批准号:8318345
-
项目类别:
-
资助金额:$9.28万
-
财政年份:2008
-
负责人:Peter Kurre
-
依托单位:
HSC transduction in situ by cellular delivery of integrating viral vectors
-
批准号:8123344
-
项目类别:
-
资助金额:$44.15万
-
财政年份:2008
-
负责人:Peter Kurre
-
依托单位:
Genetic targeting of proviral integration in stem cells
-
批准号:7625013
-
项目类别:
-
资助金额:$12.91万
-
财政年份:2005
-
负责人:Peter Kurre
-
依托单位:
Genetic targeting of proviral integration in stem cells
-
批准号:7264540
-
项目类别:
-
资助金额:$12.91万
-
财政年份:2005
-
负责人:Peter Kurre
-
依托单位:
Genetic targeting of proviral integration in stem cells
-
批准号:7089976
-
项目类别:
-
资助金额:$12.91万
-
财政年份:2005
-
负责人:Peter Kurre
-
依托单位:
Genetic targeting of proviral integration in stem cells
-
批准号:6961436
-
项目类别:
-
资助金额:$12.91万
-
财政年份:2005
-
负责人:Peter Kurre
-
依托单位:
Genetic targeting of proviral integration in stem cells
-
批准号:7458713
-
项目类别:
-
资助金额:$12.91万
-
财政年份:2005
-
负责人:Peter Kurre
-
依托单位:
海外基金